Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 19493 | 438 | 39.8 | 79% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1581 | 6646 | COCAINE//NEONATAL ABSTINENCE SYNDROME//PRENATAL COCAINE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | IMMUNOPHARMACOTHERAPY | Author keyword | 21 | 85% | 3% | 11 |
| 2 | COCAINE HYDROLASE | Author keyword | 18 | 89% | 2% | 8 |
| 3 | NICOTINE VACCINE | Author keyword | 12 | 75% | 2% | 9 |
| 4 | COCAINE VACCINE | Author keyword | 11 | 100% | 1% | 6 |
| 5 | ANTI COCAINE ANTIBODY | Author keyword | 8 | 100% | 1% | 5 |
| 6 | COCAINE ESTERASE | Author keyword | 7 | 64% | 2% | 7 |
| 7 | ADJUVANT ANTIGEN | Address | 2 | 32% | 1% | 6 |
| 8 | WORM MED WIRM | Address | 2 | 33% | 1% | 4 |
| 9 | WIRM | Address | 2 | 16% | 2% | 9 |
| 10 | WORM MED | Address | 1 | 13% | 2% | 10 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | IMMUNOPHARMACOTHERAPY | 21 | 85% | 3% | 11 | Search IMMUNOPHARMACOTHERAPY | Search IMMUNOPHARMACOTHERAPY |
| 2 | COCAINE HYDROLASE | 18 | 89% | 2% | 8 | Search COCAINE+HYDROLASE | Search COCAINE+HYDROLASE |
| 3 | NICOTINE VACCINE | 12 | 75% | 2% | 9 | Search NICOTINE+VACCINE | Search NICOTINE+VACCINE |
| 4 | COCAINE VACCINE | 11 | 100% | 1% | 6 | Search COCAINE+VACCINE | Search COCAINE+VACCINE |
| 5 | ANTI COCAINE ANTIBODY | 8 | 100% | 1% | 5 | Search ANTI+COCAINE+ANTIBODY | Search ANTI+COCAINE+ANTIBODY |
| 6 | COCAINE ESTERASE | 7 | 64% | 2% | 7 | Search COCAINE+ESTERASE | Search COCAINE+ESTERASE |
| 7 | ACUTE COCAINE TOXICITY | 1 | 100% | 0% | 2 | Search ACUTE+COCAINE+TOXICITY | Search ACUTE+COCAINE+TOXICITY |
| 8 | ANTI NICOTINE VACCINE | 1 | 100% | 0% | 2 | Search ANTI+NICOTINE+VACCINE | Search ANTI+NICOTINE+VACCINE |
| 9 | CELTIC PHARMA | 1 | 100% | 0% | 2 | Search CELTIC+PHARMA | Search CELTIC+PHARMA |
| 10 | CYTOS AG | 1 | 100% | 0% | 2 | Search CYTOS+AG | Search CYTOS+AG |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | COCAINE VACCINE | 58 | 92% | 5% | 23 |
| 2 | LONG TERM REDUCTIONS | 41 | 100% | 3% | 15 |
| 3 | PHENCYCLIDINE CONCENTRATIONS | 33 | 100% | 3% | 13 |
| 4 | ANTI METHAMPHETAMINE MONOCLONAL ANTIBODY | 21 | 90% | 2% | 9 |
| 5 | THERAPEUTIC COCAINE VACCINE | 15 | 82% | 2% | 9 |
| 6 | MORPHINE HEROIN VACCINE | 15 | 88% | 2% | 7 |
| 7 | NICOTINE SPECIFIC ANTIBODIES | 14 | 100% | 2% | 7 |
| 8 | NICOTINE VACCINE | 14 | 100% | 2% | 7 |
| 9 | PLASMA BUTYRYLCHOLINESTERASE | 11 | 78% | 2% | 7 |
| 10 | HIGH ACTIVITY MUTANTS | 10 | 73% | 2% | 8 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Vaccines against stimulants: cocaine and MA | 2014 | 8 | 28 | 68% |
| Vaccines Against Drug Abuse | 2012 | 34 | 64 | 47% |
| Therapeutic vaccines against tobacco addiction | 2013 | 11 | 22 | 64% |
| Pharmacokinetic strategies for treatment of drug overdose and addiction | 2012 | 11 | 65 | 77% |
| Immunopharmacotherapy: Vaccination strategies as a treatment for drug abuse and dependence | 2009 | 26 | 48 | 79% |
| Nicotine vaccines to treat tobacco dependence | 2013 | 6 | 49 | 73% |
| Anti-cocaine vaccine development | 2010 | 15 | 48 | 71% |
| Anti-drug vaccines to treat substance abuse | 2009 | 28 | 40 | 65% |
| Immunotherapy for the treatment of drug abuse | 2005 | 64 | 45 | 73% |
| Vaccines against nicotine | 2009 | 29 | 30 | 57% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ADJUVANT ANTIGEN | 2 | 32% | 1.4% | 6 |
| 2 | WORM MED WIRM | 2 | 33% | 0.9% | 4 |
| 3 | WIRM | 2 | 16% | 2.1% | 9 |
| 4 | WORM MED | 1 | 13% | 2.3% | 10 |
| 5 | MOL NEUROBIOL ADDICT NEUROCHEM | 1 | 40% | 0.5% | 2 |
| 6 | CHEM IMMUNOL MICROBIAL SCI | 1 | 50% | 0.2% | 1 |
| 7 | HONG KONG OFF | 1 | 50% | 0.2% | 1 |
| 8 | TOBACCO USE PROGRAMS | 1 | 50% | 0.2% | 1 |
| 9 | UQFM QUIM ORGAN | 1 | 50% | 0.2% | 1 |
| 10 | ANESTHET CRIT CARE ADDICT DRUG PROD | 0 | 33% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000183138 | COCAETHYLENE//COCAINE METABOLISM//COCAINE METABOLITES |
| 2 | 0.0000107716 | CRACK LUNG//COCAINE INDUCED SEIZURES//COCAINE TOXICITY |
| 3 | 0.0000102669 | PSYCHOBIOL SECT//BENZTROPINE ANALOGS//GBR 12909 |
| 4 | 0.0000100940 | CATALYTIC ANTIBODY//CATALYTIC ANTIBODIES//ABZYMES |
| 5 | 0.0000079232 | K VARIANT//DIBUCAINE NUMBER//SERUM CHOLINESTERASE |
| 6 | 0.0000063453 | CONTINGENCY MANAGEMENT//COCAINE DEPENDENCE//LEARNING HLTH |
| 7 | 0.0000062811 | BACLOFEN//CGP44532//POSTSYNAPTIC DOPAMINE RECEPTOR SUPERSENSITIVITY |
| 8 | 0.0000059406 | BIS7 TACRINE//BUTYRYLCHOLINESTERASE//ACETYLCHOLINESTERASE INHIBITORS |
| 9 | 0.0000058394 | 2A PEPTIDE//FMDV 2A//2A |
| 10 | 0.0000050956 | METHAMPHETAMINE//MOL NEUROPSYCHIAT SECT//MOL NEUROPSYCHIAT BRANCH |